QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morgan, E. T. Articles by Sinal, C. J. Search for Related Content PubMed PubMed Citation Articles by Morgan, E. T. Articles by Sinal, C. J.

SYMPOSIUM REPORT

Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (E.T.M., M.R.C., T.A.R.) Department of Pharmacology (K.B.G., K.W.R., C.J.S.) and College of Pharmacy (K.B.G.), Dalhousie University, Halifax, Nova Scotia, Canada; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada (M.P.-M.); Cancer Pharmacology Unit, ANZAC Research Institute, Concord, Australia (G.R.R, S.J.C., M.K.); Storr Liver Unit, Westmead Millennium Institute, Westmead, Australia (K.A.C., C.L., R.S.)

Abstract

This article is a report on a symposium sponsored by the American Society for Pharmacology and Experimental Therapeutics and held at the Experimental Biology 07 meeting in Washington, DC. The presentations discussed the phenomenology, clinical consequences, and underlying mechanisms of cytochrome P450 and drug transporter regulation by inflammatory and infectious stimuli. Although considerable insights into the links between inflammatory mediators and altered hepatic drug clearance pathways have been gained from previous studies with acute inflammatory stimuli, this symposium highlighted recent advances in understanding how these processes operate in other organs and chronic inflammatory states relevant to human diseases. The development of mouse models of live bacterial infection provides excellent opportunities to explore the impact of infection on drug metabolism beyond the well characterized effects of bacterial endotoxin. Altered levels of cytochromes P450 and especially drug transporters due to inflammation in brain, intestine, and placenta have significant implications for the use of many drugs in diverse clinical settings. The consequences of inflammatory cytokine production by tumors for drug safety and efficacy in cancer patients were outlined. Repression of drug clearance pathways by tumor-derived cytokines may result in extreme toxicity to chemotherapy, compromising treatment of many cancers. It is fitting that, in honoring the career contributions and achievements of Dr. Kenneth W. Renton, this symposium reinforced the clinical relevance of this field.

This article has been cited by other articles:

				H.-J. Zhu, D. I. Appel, Y. Jiang, and J. S. Markowitz Age- and Sex-Related Expression and Activity of Carboxylesterase 1 and 2 in Mouse and Human Liver Drug Metab. Dispos., September 1, 2009; 37(9): 1819 - 1825. [Abstract] [Full Text] [PDF]

				X. Deng, J. P. Luyendyk, P. E. Ganey, and R. A. Roth Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models Pharmacol. Rev., September 1, 2009; 61(3): 262 - 282. [Abstract] [Full Text] [PDF]

				D. J. Waxman and M. G. Holloway Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes Mol. Pharmacol., August 1, 2009; 76(2): 215 - 228. [Abstract] [Full Text] [PDF]

				B. C. Foster Therapeutic product disposition in at-risk populations Radiat Prot Dosimetry, June 1, 2009; 134(3-4): 184 - 190. [Abstract] [Full Text] [PDF]

				B. Moriyama, J. Elinoff, R. L. Danner, J. Gea-Banacloche, G. Pennick, M. G. Rinaldi, and T. J. Walsh Accelerated Metabolism of Voriconazole and Its Partial Reversal by Cimetidine Antimicrob. Agents Chemother., April 1, 2009; 53(4): 1712 - 1714. [Abstract] [Full Text] [PDF]

				M. L. Vee, V. Lecureur, B. Stieger, and O. Fardel Regulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-{alpha} or Interleukin-6 Drug Metab. Dispos., March 1, 2009; 37(3): 685 - 693. [Abstract] [Full Text] [PDF]

				J. Zhang, M. R. Chaluvadi, R. Reddy, M. S. Motika, T. A. Richardson, J. R. Cashman, and E. T. Morgan Hepatic Flavin-Containing Monooxygenase Gene Regulation in Different Mouse Inflammation Models Drug Metab. Dispos., March 1, 2009; 37(3): 462 - 468. [Abstract] [Full Text] [PDF]

				M. R. Chaluvadi, R. D. Kinloch, B. A. Nyagode, T. A. Richardson, M. J. Raynor, M. Sherman, L. Antonovic, H. W. Strobel, D. L. Dillehay, and E. T. Morgan Regulation of Hepatic Cytochrome P450 Expression in Mice with Intestinal or Systemic Infections of Citrobacter rodentium Drug Metab. Dispos., February 1, 2009; 37(2): 366 - 374. [Abstract] [Full Text] [PDF]

				R. M. Sawaya and D. S. Riddick Cytochrome P450 2C11 5'-Flanking Region and Promoter Mediate in Vivo Suppression by 3-Methylcholanthrene Drug Metab. Dispos., September 1, 2008; 36(9): 1803 - 1811. [Abstract] [Full Text] [PDF]